Drew Moghanaki
@DrewMoghanaki
MD, MPH, FASTRO - Lung Cancer Specialist & Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Pgm, VA Greater Los Angeles
Lung cancer needs to be prioritized as one of America’s top-5 public health problems. Learn how the VA understands this and is addressing it through a national initiative known as LPOP: spectrumnews1.com/ca/southern-ca…

The traits of the most respected people in a tumor board.
To strongly disagree with someone, and yet engage them with respect, grace, humility, dignity and honesty is a superpower.
We need to end the era of “I can’t see your images”. @AshleyEProsper @dramycummings #DitchTheDisk
#DitchtheDisk Important editorial in @annalsthorsurg highlighting the imperative for imaging interoperability
1% control the world. 4% are their loudspeakers. 90% are asleep. 5% are awake- trying to shake the rest. But the 1% use the 4% to silence the 5%, so the 90% never wake up.
I’ve found a lot of joy collaborating with colleagues focused on discovering insights and solutions instead of simply studying barriers. Which most recently includes Prof Nicole Rankin, who is an implementation scientist at the Melbourne School of Population and Global Health.…

“Politicians and policy makers are more likely to respond and take action if they understand the problem, the threat it poses, are offered some appraisal of the barriers and possible solutions, and the potential outcomes.” As opposed to creating shame and hysteria.
📣 Respirology Column How Do Governments Know What Needs Changing in Health Care? by Christine Jenkins onlinelibrary.wiley.com/doi/10.1111/re…
Is it true that the president elect of ESTRO is one of the international speakers at this event at @PeterMacRadOnc?
#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…
Prof Siva talks about the bold beginnings of the PRIME Lung trial and what happened next. 🎙️ Tune in to our latest episode to hear more. Listen on Apple: buff.ly/IxOhSRb Spotify: buff.ly/01rft49 Read show notes: buff.ly/0CYZlec
Is it true that @_ShankarSiva founded this conference?
#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…
Are there any treatments for metastatic cancer with a lower adverse event rate? @IyengarPuneeth @StephenVLiu
SBRT + 💊 in oligomets: 🧍♂️2294 pts | 🫁, breast, prostate, colorectal ⚠️Grade 3+ AEs: 1.5% ✅ SBRT Safe with systemic tx! #SBRT #OligoCare #ESTRO25 @EORTC @ESTRO_RT @CiroFranzese1
If you really want to know what’s going on in Russia, Ukraine, Syria, Iran, Israel, and Gaza… don’t waste your time getting brainwashed by the mainstream propaganda media. Educate yourself on the bloodlines making billions killing others over the past 20 centuries as detailed in…

Is Melbourne a nice place to visit? @_ShankarSiva
#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…
SBRT + 💊 in oligomets: 🧍♂️2294 pts | 🫁, breast, prostate, colorectal ⚠️Grade 3+ AEs: 1.5% ✅ SBRT Safe with systemic tx! #SBRT #OligoCare #ESTRO25 @EORTC @ESTRO_RT @CiroFranzese1
Is it true that this is one of the most important SABR events in the world? @_ShankarSiva
#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…
Is registration still open for this event? @_ShankarSiva
#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…
Is this event sold out already? @_ShankarSiva
#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…
The targeted radiation therapy market is ready for us. What are we waiting for? @SameerKeoleMD
RLTs huge potential
What got you here won’t get you there. What got you here might not even keep you here. Yet many people think what got them here is what will get them to the next place, and never evolve. @coachgoldsmith

It's not only humans that struggle to confirm whether surgery or SBRT is a better treatment for stage I NSCLC. Even AI-based CT modeling can't tell the difference. pubmed.ncbi.nlm.nih.gov/40563665/
